2018 - Rapid Dose Therapeutics

Latest News

April 13, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets

View News Release

April 6, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

March 26, 2026
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory

View News Release

March 5, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market

View News Release

February 23, 2026
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip™ Platform

View News Release

February 11, 2026
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors

View News Release

February 10, 2026
Rapid Dose Therapeutics Launches QuickStrip™ Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment

View News Release

January 5, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

December 8, 2025
Rapid Dose Completes Extension to Promissory Notes

View News Release

November 28, 2025
Rapid Dose Announces Extension to Promissory Notes

View News Release